secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001583648-22-000061
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris CMO Tim Demuth steps down effective Sept 30, 2022; severance of €265,125
-------------------------------------------------------------------------------

- Tim Demuth, M.D., Ph.D., Senior VP and CMO, mutually agreed to depart Pieris; effective September 30, 2022.
- Separation agreement includes 2 months base salary continuation and retirement contributions through Separation Date.
- Dr. Demuth will receive a pro-rata 2022 discretionary bonus and severance of €265,125 (~$270,427).
- Payments subject to release of claims and ongoing confidentiality obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000158364822000061/0001583648-22-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000158364822000061/pirs-20220804.htm
  HTML page:      https://secwatch.observer/filing/0001583648-22-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer